{"id":"https://openalex.org/W2040972714","doi":"https://doi.org/10.1097/00001813-199412000-00004","title":"Evaluation of antitumor activity of navelbine (vinorelbine ditartrate) against human breast carcinoma xenografts based on its pharmacokinetics in nude mice","display_name":"Evaluation of antitumor activity of navelbine (vinorelbine ditartrate) against human breast carcinoma xenografts based on its pharmacokinetics in nude mice","alternate_titles":[],"publication_year":1994,"publication_date":"1994-12-01","ids":{"openalex":"https://openalex.org/W2040972714","doi":"https://doi.org/10.1097/00001813-199412000-00004","mag":"2040972714","pmid":"https://pubmed.ncbi.nlm.nih.gov/7888700"},"language":"en","primary_location":{"id":"doi:10.1097/00001813-199412000-00004","doi":"https://doi.org/10.1097/00001813-199412000-00004","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001813-199412000-00004","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2040972714"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112158124","display_name":"Takashi TSURUO","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]},{"id":"https://openalex.org/I4405286657","display_name":"Institute for Quantitative Biosciences, The University of Tokyo","ror":"https://ror.org/02qwvne14","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4405286657","https://openalex.org/I74801974"]},{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Takashi Tsuruo","raw_affiliation_strings":["Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo","Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Kami-lkebukuro 1-37-1, Toshima-ku, Tokyo 170, Japan","Institute of Molecular and Cellular Biosciences, University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo","institution_ids":["https://openalex.org/I42570316"]},{"raw_affiliation_string":"Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Kami-lkebukuro 1-37-1, Toshima-ku, Tokyo 170, Japan","institution_ids":["https://openalex.org/I42570316"]},{"raw_affiliation_string":"Institute of Molecular and Cellular Biosciences, University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113, Japan","institution_ids":["https://openalex.org/I4405286657","https://openalex.org/I74801974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062879126","display_name":"Makoto Inaba","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Makoto Inaba","raw_affiliation_strings":["Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Kami-lkebukuro 1-37-1, Toshima-ku, Tokyo 170, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Kami-lkebukuro 1-37-1, Toshima-ku, Tokyo 170, Japan","institution_ids":["https://openalex.org/I42570316"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110143792","display_name":"Tazuko Tashiro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tazuko Tashiro","raw_affiliation_strings":["Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Kami-lkebukuro 1-37-1, Toshima-ku, Tokyo 170, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Kami-lkebukuro 1-37-1, Toshima-ku, Tokyo 170, Japan","institution_ids":["https://openalex.org/I42570316"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068738000","display_name":"Takao Yamori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Takao Yamori","raw_affiliation_strings":["Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Kami-lkebukuro 1-37-1, Toshima-ku, Tokyo 170, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Kami-lkebukuro 1-37-1, Toshima-ku, Tokyo 170, Japan","institution_ids":["https://openalex.org/I42570316"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105407717","display_name":"Yasuyuki Ohnishi","orcid":"https://orcid.org/0000-0002-8787-6720","observed_orcids":["https://orcid.org/0000-0002-8787-6720"]},"institutions":[{"id":"https://openalex.org/I20783137","display_name":"Central Institute for Experimental Animals","ror":"https://ror.org/05eagc649","country_code":"JP","type":"facility","lineage":["https://openalex.org/I20783137"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yasuyuki Ohnishi","raw_affiliation_strings":["Central Institute for Experimental Animals, Nogawa 1430, Miyamae-ku, Kawasaki-shi, Kanagawa 216, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Institute for Experimental Animals, Nogawa 1430, Miyamae-ku, Kawasaki-shi, Kanagawa 216, Japan","institution_ids":["https://openalex.org/I20783137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056653544","display_name":"Tadashi Ashizawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tadashi Ashizawa","raw_affiliation_strings":["Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd, Shimotogari 1188, Nagaizumi-cho, Sunto-gun, Shizuoka 411, Japan. Tel: (+81) 3 3816 3592; Fax: (+81) 3 3816 3592","Fax: (+81) 3 3816 3592","Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd, Shimotogari 1188, Nagaizumi-cho, Sunto-gun, Shizuoka 411, Japan. Tel: (+81) 3 3816 3592"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd, Shimotogari 1188, Nagaizumi-cho, Sunto-gun, Shizuoka 411, Japan. Tel: (+81) 3 3816 3592; Fax: (+81) 3 3816 3592","institution_ids":[]},{"raw_affiliation_string":"Fax: (+81) 3 3816 3592","institution_ids":[]},{"raw_affiliation_string":"Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd, Shimotogari 1188, Nagaizumi-cho, Sunto-gun, Shizuoka 411, Japan. Tel: (+81) 3 3816 3592","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111842852","display_name":"Toki Sakai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Toki Sakai","raw_affiliation_strings":["Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd, Shimotogari 1188, Nagaizumi-cho, Sunto-gun, Shizuoka 411, Japan. Tel: (+81) 3 3816 3592; Fax: (+81) 3 3816 3592","Fax: (+81) 3 3816 3592","Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd, Shimotogari 1188, Nagaizumi-cho, Sunto-gun, Shizuoka 411, Japan. Tel: (+81) 3 3816 3592"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd, Shimotogari 1188, Nagaizumi-cho, Sunto-gun, Shizuoka 411, Japan. Tel: (+81) 3 3816 3592; Fax: (+81) 3 3816 3592","institution_ids":[]},{"raw_affiliation_string":"Fax: (+81) 3 3816 3592","institution_ids":[]},{"raw_affiliation_string":"Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd, Shimotogari 1188, Nagaizumi-cho, Sunto-gun, Shizuoka 411, Japan. Tel: (+81) 3 3816 3592","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007319655","display_name":"Satoshi Kobayashi","orcid":"https://orcid.org/0000-0002-7760-0771","observed_orcids":["https://orcid.org/0000-0002-7760-0771"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Satoshi Kobayashi","raw_affiliation_strings":["Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd, Shimotogari 1188, Nagaizumi-cho, Sunto-gun, Shizuoka 411, Japan. Tel: (+81) 3 3816 3592; Fax: (+81) 3 3816 3592","Fax: (+81) 3 3816 3592","Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd, Shimotogari 1188, Nagaizumi-cho, Sunto-gun, Shizuoka 411, Japan. Tel: (+81) 3 3816 3592"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd, Shimotogari 1188, Nagaizumi-cho, Sunto-gun, Shizuoka 411, Japan. Tel: (+81) 3 3816 3592; Fax: (+81) 3 3816 3592","institution_ids":[]},{"raw_affiliation_string":"Fax: (+81) 3 3816 3592","institution_ids":[]},{"raw_affiliation_string":"Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd, Shimotogari 1188, Nagaizumi-cho, Sunto-gun, Shizuoka 411, Japan. Tel: (+81) 3 3816 3592","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111450749","display_name":"Katsushige Gomi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Katsushige Gomi","raw_affiliation_strings":["Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd, Shimotogari 1188, Nagaizumi-cho, Sunto-gun, Shizuoka 411, Japan. Tel: (+81) 3 3816 3592; Fax: (+81) 3 3816 3592","Fax: (+81) 3 3816 3592","Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd, Shimotogari 1188, Nagaizumi-cho, Sunto-gun, Shizuoka 411, Japan. Tel: (+81) 3 3816 3592"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd, Shimotogari 1188, Nagaizumi-cho, Sunto-gun, Shizuoka 411, Japan. Tel: (+81) 3 3816 3592; Fax: (+81) 3 3816 3592","institution_ids":[]},{"raw_affiliation_string":"Fax: (+81) 3 3816 3592","institution_ids":[]},{"raw_affiliation_string":"Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd, Shimotogari 1188, Nagaizumi-cho, Sunto-gun, Shizuoka 411, Japan. Tel: (+81) 3 3816 3592","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3678,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.60639047,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":95},"biblio":{"volume":"5","issue":"6","first_page":"634","last_page":"640"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.8252000212669373,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.8252000212669373,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.11410000175237656,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.007499999832361937,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vinorelbine","display_name":"vinorelbine","score":0.9860000014305115},{"id":"https://openalex.org/keywords/vinca-alkaloids","display_name":"vinca alkaloids","score":0.9539999961853027},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8640000224113464},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.8090000152587891},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8759999871253967},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9300000071525574},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8629999756813049},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.6959999799728394},{"id":"https://openalex.org/keywords/auc","display_name":"AUC","score":0.5699999928474426},{"id":"https://openalex.org/keywords/intermittent-dosing","display_name":"intermittent dosing","score":0.5590000152587891},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.7570000290870667},{"id":"https://openalex.org/keywords/toxicity","display_name":"toxicity","score":0.39500001072883606},{"id":"https://openalex.org/keywords/nude-mice","display_name":"nude mice","score":0.7739999890327454}],"concepts":[{"id":"https://openalex.org/C2776553716","wikidata":"https://www.wikidata.org/wiki/Q3559405","display_name":"Vinca alkaloid","level":5,"score":0.8604897260665894},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7444203495979309},{"id":"https://openalex.org/C2777096885","wikidata":"https://www.wikidata.org/wiki/Q220925","display_name":"Vinca","level":2,"score":0.6899631023406982},{"id":"https://openalex.org/C2780350996","wikidata":"https://www.wikidata.org/wiki/Q420532","display_name":"Vinorelbine","level":4,"score":0.6354274749755859},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5336469411849976},{"id":"https://openalex.org/C2994423619","wikidata":"https://www.wikidata.org/wiki/Q9103","display_name":"Human breast","level":4,"score":0.46847572922706604},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.43017563223838806},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.407856822013855},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4001803696155548},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35780590772628784},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2971354126930237},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.23955687880516052},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19572120904922485},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.194767564535141},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.1309252679347992},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.06747931241989136},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077235","descriptor_name":"Vinorelbine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000231","descriptor_name":"Adenocarcinoma, Papillary","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000231","descriptor_name":"Adenocarcinoma, Papillary","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014183","descriptor_name":"Transplantation, Heterologous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018276","descriptor_name":"Carcinoma, Medullary","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018276","descriptor_name":"Carcinoma, Medullary","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00001813-199412000-00004","doi":"https://doi.org/10.1097/00001813-199412000-00004","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001813-199412000-00004","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},{"id":"pmid:7888700","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7888700","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2306716866","https://openalex.org/W2164672167","https://openalex.org/W2065563161","https://openalex.org/W1978570638","https://openalex.org/W2426979238","https://openalex.org/W2397907227","https://openalex.org/W2085672985","https://openalex.org/W2346909673","https://openalex.org/W1981867528","https://openalex.org/W2080201768"],"abstract_inverted_index":{"The":[0,40,87,101,245],"in":[1,92,216],"vitro":[2],"antitumor":[3,183,209,239],"activity":[4,184,240],"of":[5,18,43,53,84,90,103,116,134,185,191,199,218],"navelbine":[6],"(NVB,":[7,136],"KW-2307),":[8],"a":[9,68,82,131,207],"newly":[10],"synthesized":[11],"vinca":[12],"alkaloid,":[13],"was":[14,74,105,143,157,172,231,249],"compared":[15,129,175,223],"with":[16,176,224],"that":[17,95,177,181,190],"adriamycin":[19],"(ADM)":[20],"against":[21,145,160,241],"human":[22,123],"breast":[23],"carcinomas":[24],"inoculated":[25],"into":[26,48],"nude":[27,49,126],"mice":[28,50],"at":[29,51,81,119,193,201,226,234],"the":[30,61,114,163,166,182],"maximum":[31],"tolerated":[32],"dose":[33,38,83],"(MTD)":[34],"and":[35,55,125,153,211],"clinically":[36],"equivalent":[37],"(CED).":[39],"plasma":[41,93],"levels":[42],"NVB":[44,73,91,96,104,142,171,186,200,230],"after":[45,79],"intravenous":[46],"injection":[47,133,198],"doses":[52],"1.2":[54],"4.8":[56,85,110],"mg/kg":[57,111],"diminished":[58],"rapidly":[59],"during":[60],"early":[62],"phase":[63],"(0-1":[64],"h),":[65],"followed":[66],"by":[67,130,170,178],"very":[69],"long":[70],"shallow":[71],"one.":[72],"still":[75,250],"detected":[76],"96":[77],"h":[78,121],"administration":[80],"mg/kg.":[86],"pharmacokinetic":[88],"parameters":[89],"indicated":[94],"extensively":[97],"distributes":[98],"to":[99,108,189],"tissues.":[100],"CED":[102,203],"provisionally":[106],"decided":[107],"be":[109],"based":[112],"on":[113,253],"comparison":[115],"AUC":[117],"values":[118],"24-infinity":[120],"between":[122],"patients":[124],"mice.":[127],"When":[128],"single":[132,197],"MTD":[135],"16":[137],"mg/kg;":[138],"ADM":[139,156,192],"12":[140],"mg/kg),":[141],"effective":[144,158],"all":[146],"four":[147],"tumor":[148,243],"lines,":[149],"MC-2,":[150],"MC-8,":[151],"MMKY":[152],"H-31,":[154],"while":[155],"only":[159],"H-31.":[161],"On":[162],"other":[164],"hand,":[165],"body":[167,219,246],"weight":[168,220,247],"loss":[169,248],"mild":[173,251],"as":[174,222],"ADM,":[179],"indicating":[180],"is":[187],"superior":[188],"their":[194],"MTDs.":[195],"A":[196],"its":[202],"(4.8":[204],"mg/kg)":[205],"produced":[206],"poor":[208],"effect":[210],"no":[212],"or":[213],"little":[214],"toxicity":[215],"terms":[217],"loss,":[221],"those":[225],"MTD.":[227],"However,":[228],"when":[229],"administered":[232],"intermittently":[233],"CED,":[235],"it":[236],"exhibited":[237],"significant":[238],"three":[242],"lines.":[244],"even":[252],"this":[254],"intermittent":[255],"schedule.(ABSTRACT":[256],"TRUNCATED":[257],"AT":[258],"250":[259],"WORDS)":[260]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2040972714","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
